Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults
- PMID: 18799442
- DOI: 10.1001/jama.300.11.1303
Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults
Abstract
Context: Bisphenol A (BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low-level chronic exposures in humans.
Objective: To examine associations between urinary BPA concentrations and adult health status.
Design, setting, and participants: Cross-sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003-2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios (ORs) of 1.4 for diagnoses of 5% prevalence per 1-SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P < .05.
Main outcome measures: Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes.
Results: Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.18-1.63; P = .001 with full adjustment). Higher BPA concentrations were also associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma-glutamyltransferase (OR per 1-SD increase in BPA concentration, 1.29; 95% CI, 1.14-1.46; P < .001) and alkaline phosphatase (OR per 1-SD increase in BPA concentration, 1.48; 95% CI, 1.18-1.85; P = .002).
Conclusion: Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community-dwelling adult population.
Comment in
-
Bisphenol A and risk of metabolic disorders.JAMA. 2008 Sep 17;300(11):1353-5. doi: 10.1001/jama.300.11.1353. Epub 2008 Sep 16. JAMA. 2008. PMID: 18799451 No abstract available.
-
Association of bisphenol A with diabetes and other abnormalities.JAMA. 2009 Feb 18;301(7):720-1; author reply 721-2. doi: 10.1001/jama.2009.122. JAMA. 2009. PMID: 19224743 No abstract available.
-
Association of bisphenol A with diabetes and other abnormalities.JAMA. 2009 Feb 18;301(7):720; author reply 721-2. doi: 10.1001/jama.2009.121. JAMA. 2009. PMID: 19224744 No abstract available.
-
Association of bisphenol A with diabetes and other abnormalities.JAMA. 2009 Feb 18;301(7):720; author reply 721-2. doi: 10.1001/jama.2009.120. JAMA. 2009. PMID: 19224745 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
